Laboratoires Thea
Clinical trials sponsored by Laboratoires Thea, explained in plain language.
-
New eye drop could offer relief for kids with severe eye allergies
Disease control Recruiting nowThis study tests a new eye drop called T1695 against an existing treatment (ciclosporin) for children aged 4 to 17 with moderate to severe vernal keratoconjunctivitis, a serious allergic eye condition. The goal is to see if T1695 is more effective at reducing eye surface damage a…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Could these eye drops stop Kids' nearsightedness from getting worse?
Disease control Recruiting nowThis study tests whether T10430 eye drops can safely slow the progression of nearsightedness (myopia) in children aged 6 to 12. Myopia often starts in childhood and can lead to serious eye problems later in life. The trial will measure side effects and how well the drops control …
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC